Literature DB >> 9178687

Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract.

K Krempels1, B Hunyady, A M O'Carroll, E Mezey.   

Abstract

BACKGROUND & AIMS: The gastrointestinal (GI) tract is a major source and target of somatostatin (SRIF). Recently, five pharmacologically different SRIF receptors (sst1-5) were cloned. The cellular and tissue distribution of the sst1-5 messenger RNAs (mRNAs) were studied in the rat GI tract using in situ hybridization histochemistry (ISHH).
METHODS: Two sets of (35)S-uridine triphosphate (UTP)-labeled antisense and sense riboprobes were prepared for each sst. ISHH was conducted on frozen tissue samples from rat stomach, duodenum, jejunum, ileum, colon, and pancreas.
RESULTS: mRNAs of all five sst-s are widely expressed in the rat GI tract. The distribution pattern for each sst mRNA was identical with both antisense probes. No specific signal was found with any of the sense probes. Each layer of the different parts of the gut expressed mRNAs of multiple sst subtypes. All organs expressed sst3 mRNA very intensely. The lowest levels of mRNA expression for all five subtypes within the GI tract were found in the pancreas.
CONCLUSIONS: The widespread expression of sst mRNAs suggests a significant role for SRIF in the regulation of GI function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178687     DOI: 10.1053/gast.1997.v112.pm9178687

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Role of somatostatin receptors on gastric acid secretion in wild-type and somatostatin receptor type 2 knockout mice.

Authors:  Laura Piqueras; Vicente Martínez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-20       Impact factor: 3.000

2.  Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach.

Authors:  Vidar Fykse; David H Coy; Helge Lyder Waldum; Arne Kristian Sandvik
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

3.  Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice.

Authors:  Agata Mulak; Muriel Larauche; Mandy Biraud; Mulugeta Million; Jean Rivier; Yvette Taché
Journal:  Peptides       Date:  2014-11-05       Impact factor: 3.750

4.  Somatostatin antagonism prevents elemental diet-induced intestinal atrophy in the rat.

Authors:  I A Gómez de Segura; T Castell; I Vázquez; A Mata; E De Miguel
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

5.  Somatostatin receptor type 2 mediates bombesin-induced inhibition of gastric acid secretion in mice.

Authors:  Laura Piqueras; Yvette Taché; Vicente Martínez
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

6.  Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor.

Authors:  Weifang Rong; Wendy J Winchester; David Grundy
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

7.  Peripheral PACAP inhibits gastric acid secretion through somatostatin release in mice.

Authors:  Laura Piqueras; Yvette Taché; Vicente Martínez
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

8.  Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides.

Authors:  Erik Vegt; Annemarie Eek; Wim J G Oyen; Marion de Jong; Martin Gotthardt; Otto C Boerman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

9.  Regulation of colonic apical potassium (BK) channels by cAMP and somatostatin.

Authors:  M D Perry; G I Sandle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

10.  Activation of Muscarinic Acetylcholine Receptor Subtype 4 Is Essential for Cholinergic Stimulation of Gastric Acid Secretion: Relation to D Cell/Somatostatin.

Authors:  Koji Takeuchi; Takuya Endoh; Shusaku Hayashi; Takeshi Aihara
Journal:  Front Pharmacol       Date:  2016-08-30       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.